|
Beurs gesloten -
Andere beurzen
|
Nabeurs 20:42:04 | |||
| 83,60 EUR | -1,65% |
|
83,45 | -0,18% |
| 17:20 | Sanofi waarschuwt voor tekort aan Insuline Lispro-pennen, meldt EMA | RE |
| 17:02 | Europese aandelen als ADR's in de VS nauwelijks gewijzigd op maandag | MT |
Voorlopige winst- en verliesrekening: Sanofi
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 36.041 | 37.761 | 42.997 | 43.070 | 41.081 | 43.479 | 46.507 | 49.535 |
| Variatie | - | 4,77% | 13,87% | 0,17% | -4,62% | 5,84% | 6,96% | 6,51% |
| EBITDA 1 | 11.443 | 12.183 | 14.627 | 14.259 | 12.889 | 13.385 | 14.448 | 15.429 |
| Variatie | - | 6,47% | 20,06% | -2,52% | -9,61% | 3,85% | 7,94% | 6,79% |
| Bedrijfsresultaat (EBIT) 1 | 9.762 | 10.714 | 13.040 | 12.670 | 11.343 | 12.026 | 13.051 | 14.022 |
| Variatie | - | 9,75% | 21,71% | -2,84% | -10,47% | 6,02% | 8,53% | 7,44% |
| Betaalde rente 1 | -337 | -328 | -234 | -722 | -554 | -331 | -442,8 | -355,2 |
| Resultaat voor belastingen (EBT) 1 | 13.804 | 7.798 | 8.268 | 7.038 | 6.997 | 8.982 | 10.181 | 11.372 |
| Variatie | - | -43,51% | 6,03% | -14,88% | -0,58% | 28,36% | 13,35% | 11,7% |
| Nettowinst (verlies) 1 | 12.314 | 6.223 | 6.720 | 5.400 | 5.744 | 8.333 | 8.319 | 9.204 |
| Variatie | - | -49,46% | 7,99% | -19,64% | 6,37% | 45,07% | -0,16% | 10,64% |
| Datum van publicatie | 5/02/21 | 4/02/22 | 3/02/23 | 1/02/24 | 30/01/25 | - | - | - |
1EUR in Miljoen
Geschatte gegevens
Balansprognose: Sanofi
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuld 1 | 8.789 | 9.983 | 6.437 | 7.793 | 8.772 | 12.329 | 9.908 | 6.764 |
| Variatie | - | 13,59% | -35,52% | 21,07% | 12,56% | 40,55% | -19,64% | -31,73% |
| Datum van publicatie | 5/02/21 | 4/02/22 | 3/02/23 | 1/02/24 | 30/01/25 | - | - | - |
1EUR in Miljoen
Geschatte gegevens
Verwachte kasstroom: Sanofi
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 1.329 | 2.043 | 2.201 | 3.024 | 1.808 | 1.976 | 2.106 | 2.188 |
| Variatie | - | 53,72% | 7,73% | 37,39% | -40,21% | 9,3% | 6,56% | 3,91% |
| Vrije kasstroom (FCF) 1 | 6.982 | 8.096 | 8.483 | 8.478 | 5.955 | 6.159 | 9.046 | 10.013 |
| Variatie | - | 15,96% | 4,78% | -0,06% | -29,76% | 3,43% | 46,87% | 10,69% |
| Datum van publicatie | 5/02/21 | 4/02/22 | 3/02/23 | 1/02/24 | 30/01/25 | - | - | - |
1EUR in Miljoen
Geschatte gegevens
Verwachte financiële ratio's: Sanofi
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
Winstgevendheid | ||||||||
| EBITDA-marge (%) | 31,75% | 32,26% | 34,02% | 33,11% | 31,37% | 30,79% | 31,07% | 31,15% |
| EBIT-marge (%) | 27,09% | 28,37% | 30,33% | 29,42% | 27,61% | 27,66% | 28,06% | 28,31% |
| EBT-marge (%) | 38,3% | 20,65% | 19,23% | 16,34% | 17,03% | 20,66% | 21,89% | 22,96% |
| Nettomarge (%) | 34,17% | 16,48% | 15,63% | 12,54% | 13,98% | 19,16% | 17,89% | 18,58% |
| FCF-marge (%) | 19,37% | 21,44% | 19,73% | 19,68% | 14,5% | 14,17% | 19,45% | 20,21% |
| Vrije kasstroom/nettoresultaat (%) | 56,7% | 130,1% | 126,24% | 157% | 103,67% | 73,92% | 108,74% | 108,79% |
Winstgevendheid | ||||||||
| ROA | 6,47% | 5,3% | 8,37% | 4,27% | 4,43% | 6,73% | 6,74% | 6,97% |
| ROE | 12,05% | 12,46% | 14,42% | 13,65% | 11,75% | 12,3% | 12,87% | 13,4% |
Financiële gezondheid | ||||||||
| Hefboom (schuld/ebitda) | 0,77x | 0,82x | 0,44x | 0,55x | 0,68x | 0,92x | 0,69x | 0,44x |
| Schuld/vrije kasstroom | 1,26x | 1,23x | 0,76x | 0,92x | 1,47x | 2x | 1,1x | 0,68x |
Kapitaalintensiteit | ||||||||
| Kapitaaluitgaven/omzet (%) | 3,69% | 5,41% | 5,12% | 7,02% | 4,4% | 4,55% | 4,53% | 4,42% |
| CAPEX / EBITDA (%) | 11,61% | 16,77% | 15,05% | 21,21% | 14,03% | 14,76% | 14,58% | 14,18% |
| CAPEX / FCF (%) | 19,03% | 25,23% | 25,95% | 35,67% | 30,36% | 32,08% | 23,28% | 21,85% |
Bestanddelen per aandeel | ||||||||
| Kasstroom per aandeel 1 | 5,942 | 8,365 | 8,408 | 8,195 | 7,857 | 9,788 | 9,798 | 10,39 |
| Variatie | - | 40,77% | 0,52% | -2,53% | -4,13% | 24,58% | 0,1% | 6,07% |
| Dividend per aandeel 1 | 3,2 | 3,33 | 3,56 | 3,76 | 3,92 | 4,157 | 4,291 | 4,543 |
| Variatie | - | 4,06% | 6,91% | 5,62% | 4,26% | 6,04% | 3,23% | 5,87% |
| Nettoactief per aandeel 1 | 50,26 | 54,84 | 59,74 | 59,15 | 62,08 | 64,41 | 67,44 | 70,67 |
| Variatie | - | 9,11% | 8,94% | -0,98% | 4,96% | 3,75% | 4,7% | 4,79% |
| WPA 1 | 9,82 | 4,97 | 5,37 | 4,31 | 4,59 | 6,875 | 6,879 | 7,642 |
| Variatie | - | -49,39% | 8,05% | -19,74% | 6,5% | 49,79% | 0,05% | 11,1% |
| Aantal aandelen (in duizend) | 1.256.375 | 1.255.293 | 1.254.060 | 1.253.891 | 1.247.793 | 1.216.810 | 1.216.810 | 1.216.810 |
| Datum van publicatie | 5/02/21 | 4/02/22 | 3/02/23 | 1/02/24 | 30/01/25 | - | - | - |
1EUR
Geschatte gegevens
| 2025 * | 2026 * | |
|---|---|---|
| k/w-verhouding | 12,4x | 12,4x |
| PBR-ratio | 1,32x | 1,26x |
| EV/omzet | 2,66x | 2,44x |
| Dividendrendement | 4,89% | 5,05% |
Meer waarderingsratio's
* Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Trader
Trader
Beleggings
Beleggings
Globaal
Globaal
Kwaliteit van de publicaties
Kwaliteit van de publicaties
ESG MSCI
A
Verkoop
Koop
Gemiddeld advies
Kopen
Aantal analisten
22
Laatste slotkoers
85,00EUR
Gemiddelde koersdoel
105,67EUR
Spread / Gemiddelde doel
+24,32%
Kwartaalomzet - Afwijkingspercentage
Kies jouw editie
Alle financiële informatie op nationaal niveau
